Werewolf Therapeutics (HOWL) Debt to Equity (2023 - 2025)
Werewolf Therapeutics (HOWL) has disclosed Debt to Equity for 3 consecutive years, with $0.73 as the latest value for Q3 2025.
- On a quarterly basis, Debt to Equity rose 155.15% to $0.73 in Q3 2025 year-over-year; TTM through Sep 2025 was $0.73, a 155.15% increase, with the full-year FY2024 number at $0.36, up 21.27% from a year prior.
- Debt to Equity was $0.73 for Q3 2025 at Werewolf Therapeutics, up from $0.6 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $0.73 in Q3 2025 to a low of $0.24 in Q1 2024.
- A 3-year average of $0.38 and a median of $0.33 in 2023 define the central range for Debt to Equity.
- Peak YoY movement for Debt to Equity: fell 26.86% in 2024, then skyrocketed 155.15% in 2025.
- Werewolf Therapeutics' Debt to Equity stood at $0.29 in 2023, then grew by 21.27% to $0.36 in 2024, then surged by 105.67% to $0.73 in 2025.
- Per Business Quant, the three most recent readings for HOWL's Debt to Equity are $0.73 (Q3 2025), $0.6 (Q2 2025), and $0.46 (Q1 2025).